https://www.selleckchem.com/pr....oducts/chir-99021-ct
DISM group 3 (IQR 1-6), p  0.001]. The length of hospital stay and overall mortality rate of DCS group were not significant statistical differences with DISM group. Complications rate related to primary anastomosis or primary ostomy was similar. There is not difference in ostomy rate among groups. At multivariate analysis, SOFA  6 points and APACHE-II  20 points correlated with a higher probability of DCS. DCS in severe non-trauma peritonitis patients is feasible and safe as surgical strategy management withou

https://www.selleckchem.com/pr....oducts/vorapaxar.htm
Background Cholecystectomy (CCY) is the only definitive therapy for acute cholecystitis. We conducted this study to evaluate which patients may not benefit from further CCY after percutaneous transhepatic gallbladder drainage (PTGBD) has been performed in acute cholecystitis patients. Methods Acute cholecystitis patients with PTGBD treatment were selected from one million random samples from the National Health Insurance Research Database obtained between January 2004 and December 2010. Recurrent biliary events (RBEs), RBE-related med